Anti-tumor necrosis factor alpha (TNF-α) agents are used in a variety of inflammatory diseases, including inflammatory bowel diseases (IBD), rheumatic diseases (rheumatoid arthritis (RA) and axial spondyloarthritis), and psoriasis [1]. This evidence concerns the gene TNF and rheumatoid arthritis.